Parvin Fardipour, Ph.D. has been appointed vice president of Adaptive Clinical Trials at Aptiv Solutions. Dr. Fardipour will work with sponsors to identify opportunities for applying adaptive designs to their clinical trials to optimize study data. She has 23 years of experience managing adaptive trials in global pharmaceutical companies.
Most recently, Dr. Fardipour worked at Theorem Clinical Research as director of Global Statistical Programming, where she directed the successful execution of a Phase II/III combined study. Prior to Theorem, she spent 16 years at Wyeth, where she ultimately served as senior director of Adaptive Trials and Applied Program Strategies.
“We are thrilled to have Parvin joining our team of adaptive clinical trials experts,” said Pat Donnelly, chairman and chief executive officer of Aptiv Solutions, “She brings unmatched experience to Aptiv Solutions having successfully designed and executed more than 20 adaptive trials during the past seven years.”